Atra stock forecast.

Oct 13, 2023 · Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025?

Atra stock forecast. Things To Know About Atra stock forecast.

ATRA | Atara Biotherapeutics, Inc. Healthcare NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario . 📊 Technical analysis helps id 📈 …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. Atara Biotherapeutics Inc. (ATRA) Company Description. Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188 ...

2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...

$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...

2 Wall Street research analysts have issued twelve-month price objectives for Nano-X Imaging's shares. Their NNOX share price targets range from $14.50 to $30.00. On average, they anticipate the company's stock price to reach $22.25 in the next year. This suggests a possible upside of 253.7% from the stock's current price.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025?

The average Tempest Therapeutics stock price prediction forecasts a potential upside of 1,156.68% from the current TPST share price of $3.74. What is TPST's forecast return on equity (ROE) for 2023-2026? (NASDAQ: TPST) forecast ROE is N/A, which is …

Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.

allforecast.comThe average Atara Biotherapeutics stock price prediction forecasts a potential upside of 1,854.55% from the current ATRA share price of $0.57. What is ATRA's forecast return on equity (ROE) for 2023-2026?Atara Biotherapeutics Stock Forecast 01 Nov. Presumably, on 11/01/2023, the price of shares will be in the range of $1.26 - $1.29. A $0.03 range width can provide …1 Wall Street analysts have issued twelve-month price objectives for ARMOUR Residential REIT's shares. Their ARR share price targets range from $20.00 to $25.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.3 Wall Street research analysts have issued 12 month price targets for Invesco Mortgage Capital's stock. Their IVR share price targets range from $10.50 to $11.00. On average, they expect the company's stock price to reach $10.75 in the next year. This suggests a possible upside of 31.0% from the stock's current price.Should You Buy or Sell Arrival Stock? Get The Latest ARVL Stock Analysis, Price Target, Headlines, Short Interest at MarketBeat. ... View our ARVL earnings forecast. When did Arrival's stock split? Arrival shares reverse split before market open on Friday, April 14th 2023. The 1-50 reverse split was announced on Friday, April 14th 2023.Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Pessimistic forecast: 1.89. Optimistic: 1.93. Atara Biotherapeutics stock forecast for 19.11.2023.

13 analysts have issued 12-month price targets for Delta Air Lines' shares. Their DAL share price targets range from $39.00 to $77.00. On average, they predict the company's stock price to reach $54.40 in the next year. This suggests a possible upside of 43.0% from the stock's current price.Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Nov 24, 2023 · Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58. Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.The average Geovax Labs stock price prediction forecasts a potential upside of 1,542.71% from the current GOVX share price of $0.49. What is GOVX's forecast return on equity (ROE) for 2026-2026? (NASDAQ: GOVX) forecast ROE is N/A, which is considered weak.

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ... Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of 1,655.27%. The lowest target is $0.50 and the highest is $25. On average, analysts rate ATRA stock stock as a hold.

So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. -6,390.31% -223.52%Fintel reports that on November 9, 2023, Mizuho downgraded their outlook for Atara Biotherapeutics (NASDAQ:ATRA) from Buy to Neutral . Analyst Price Forecast Suggests 1,140.58% Upside As of ...The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA.This page offers a collection of popular stock exchanges and their most prominent stocks for which our website offers price predictions. Clicking on names of the stocks will bring you to the price forecasts, while choosing the stock market will list the available stocks on the market. Vanguard Group, Inc. - Vanguard Energy ETF Pakistan ...Find the latest dividend history for Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com.According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Atara Biotherapeutics Stock Forecast 01 Nov. Presumably, on 11/01/2023, the price of shares will be in the range of $1.26 - $1.29. A $0.03 range width can provide …

Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.

Atara Biotherapeutics Stock Forecast 02 Nov. Presumably, on 11/02/2023, the price of shares will be in the range of $1.24 - $1.28. A $0.04 range width can provide 3.46% volatility. The weighted average price of this range is at $1.26, which is $0.01 lower than the previous day's weighted average price.High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year.THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …AT&T (NYSE:T) pays an annual dividend of $1.11 per share and currently has a dividend yield of 6.81%. T has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for T.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...1 Wall Street analysts have issued twelve-month price objectives for ARMOUR Residential REIT's shares. Their ARR share price targets range from $20.00 to $25.00. On average, they anticipate the company's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.Sep 19, 2023 · Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58. 12 brokers have issued 1 year price objectives for TC Energy's stock. Their TRP share price targets range from C$47.00 to C$64.00. On average, they expect the company's share price to reach C$55.06 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price. View analysts price targets for TRP or …Nov 16, 2023 · With Atara Biotherapeutics stock trading at $0.38 per share, the total value of Atara Biotherapeutics stock (market capitalization) is $38.73M. Atara Biotherapeutics stock was originally listed at a price of $10.65 in Oct 16, 2014. If you had invested in Atara Biotherapeutics stock at $10.65, your return over the last 9 years would have been ... Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...Stock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy.KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

ATRA Stock Predictions, Articles, and Atara Biotherap News From InvestorPlace From the Web Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday By William White, ...Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? Nov 2, 2023 · On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00. Instagram:https://instagram. kold stock forecastoptions trading spyforex platforms usabest stock brokers for day trading Atara Biotherapeutics, Inc. (Ticker: ATRA) closed the trading day on December 1, 2023, with a slight decline of 1.85%, ending the session at $0.65. The stock traded within a range of $0.57 to $0.65 on the same day, indicating a degree of volatility. ... the stock's technical outlook and negative profitability metrics pose considerable risks for ...The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 … stocks and cryptojoint corp The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million. cxai stock forecast On average, Wall Street analysts predict that Atara Biotherapeutics 's share price could reach $11.18 by Nov 10, 2024. The average Atara Biotherapeutics stock price …ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.